Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study.
Kaku H, Kumagai S, Onoue H, Takada A, Shoji T, Miura F, Yoshizaki A, Sato S, Kigawa J, Arai T, Tsunoda S, Tominaga E, Aoki D, Sugiyama T. Kaku H, et al. Among authors: kumagai s. Exp Ther Med. 2012 Jan;3(1):60-65. doi: 10.3892/etm.2011.375. Epub 2011 Oct 24. Exp Ther Med. 2012. PMID: 22969845 Free PMC article.
Does severe anemia caused by dose-dense paclitaxel-Carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trial.
Kumagai S, Sugiyama T, Shoji T, Michimae H, Katsumata N, Aoki D, Terauchi F, Jobo T, Ochiai K, Yasuda M. Kumagai S, et al. Int J Gynecol Cancer. 2011 Dec;21(9):1585-91. doi: 10.1097/IGC.0b013e318229266a. Int J Gynecol Cancer. 2011. PMID: 22123713 Clinical Trial.
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Shoji T, Takatori E, Omi H, Kumagai S, Yoshizaki A, Yokoyama Y, Mizunuma H, Fujimoto T, Takano T, Yaegashi N, Tase T, Nakahara K, Kurachi H, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: kumagai s. Int J Gynecol Cancer. 2011 Jan;21(1):44-50. doi: 10.1097/IGC.0b013e3181ffbe9f. Int J Gynecol Cancer. 2011. PMID: 21330830 Clinical Trial.
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T, Takatori E, Furutake Y, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Kumagai S, Yoshizaki A, Sato A, Sugiyama T. Shoji T, et al. Among authors: kumagai s. Int J Clin Oncol. 2016 Dec;21(6):1120-1127. doi: 10.1007/s10147-016-1008-7. Epub 2016 Jun 24. Int J Clin Oncol. 2016. PMID: 27342833 Free PMC article. Clinical Trial.
953 results